INCOME TAXES (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| INCOME TAXES | |||
| Increase in valuation allowance | $ 4,392,000 | $ 4,045,000 | |
| Federal income tax rate | 21.00% | 21.00% | 21.00% |
| Effective tax rate | 0.00% | 0.00% | |
| Gross deferred tax asset | $ 2,256,000 | ||
| Deferred tax assets: | |||
| Net operating losses | 3,334,000 | $ 1,945,000 | |
| Due to Officers | 1,411,000 | ||
| Accrued Expenses and Other | 189,000 | 212,000 | |
| R&D Credit Carryforward | 76,000 | 102,000 | |
| Debt related activities | 375,000 | ||
| Stock Compensation | 178,000 | ||
| R&D Capitalization | 581,000 | ||
| Intangibles | 34,000 | ||
| Total gross deferred tax assets/(liabilities) | 4,392,000 | 4,045,000 | |
| Less valuation allowance | (4,392,000) | (4,045,000) | |
| Federal | |||
| INCOME TAXES | |||
| Net operating loss carryforward | 12,951,000 | $ 6,482,000 | |
| Federal | Research and Development (R&D) tax credit | |||
| INCOME TAXES | |||
| Tax credit carry-forwards | 76,000 | ||
| State | |||
| INCOME TAXES | |||
| Net operating loss carryforward | $ 12,951,000 | ||
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalization of research and development costs in accordance with IRC 174. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to Debt related. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax assets attributable to deductible temporary differences from accrued expenses and expenses classified as other. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|